COSCOPIN COUGH LINCTUS 100 ML

Coscopin Cough Linctus 100 ml is used to suppress dry coughs. It is an antitussive, working by reducing the cough impulse.

The main ingredient in Coscopin Cough Linctus is Noscapine, which is an antitussive.

Coscopin Cough Linctus should be stored at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Common side effects of Coscopin Cough Linctus may include dizziness, drowsiness, or nausea. Consult a doctor if any serious side effects occur.

It is important to consult a doctor before taking Coscopin Cough Linctus during pregnancy. They will be able to advise you on the potential risks and benefits.

Consult a pediatrician before giving Coscopin Cough Linctus to children. The dosage will depend on the child's age and weight.

The dosage for Coscopin Cough Linctus should be as directed by a doctor. Typically, the dosage for adults is 5 ml three times a day.

Coscopin Cough Linctus can be taken with or without food, but it is best to take it the same way each time.

If you miss a dose of Coscopin Cough Linctus, take it as soon as you remember. If it is close to your next dose, skip the missed dose and continue with your regular dosing schedule.

Coscopin Cough Linctus can interact with certain medications. Tell your doctor about all the medications you are taking.

Coscopin Cough Linctus usually takes 30 to 60 minutes to start working.

No, Coscopin Cough Linctus is not addictive.

Symptoms of a Coscopin Cough Linctus overdose may include drowsiness, dizziness, confusion, and difficulty breathing.

If you are allergic to Coscopin Cough Linctus, stop using it and seek medical advice immediately.

Coscopin Cough Linctus is specifically effective for dry coughs. It may not be suitable for other types of coughs.

Coscopin is a combination cough preparation that usually contains ammonium chloride, noscapine, and sodium or trisodium citrate. It is used for the symptomatic relief of cough associated with conditions such as common cold, upper respiratory tract infections, and bronchitis, particularly when there is thick or irritating mucus. It helps reduce cough frequency and facilitates the clearance of secretions but does not cure the underlying disease causing the cough.

Coscopin works through the combined actions of its ingredients. Noscapine is a centrally acting antitussive that reduces the sensitivity of the cough centre in the brain, thereby decreasing the urge to cough. Ammonium chloride acts as an expectorant, helping to loosen and thin mucus in the airways so it can be expelled more easily. Sodium or trisodium citrate acts as an alkalinising agent and can help modify bronchial secretions and reduce irritation in the throat. Together, these effects provide symptomatic relief from troublesome cough.

Coscopin is generally intended for short‑term relief of dry or minimally productive cough associated with respiratory tract irritation and infections. It may not be appropriate for chronic cough due to asthma, COPD, gastro‑oesophageal reflux disease, heart failure, or long‑standing smoking‑related disease. It should be used with caution in patients with significant mucus production, because excessive suppression of cough can impair clearance of secretions. A healthcare professional should determine whether Coscopin is suitable for a particular type of cough.

The safety and appropriate use of Coscopin in children depend on age, body weight, and national or regional guidelines. Some noscapine‑containing cough preparations are not recommended in very young children due to the risk of central nervous system effects and accidental overdose. Because specific paediatric dosing and age restrictions vary by product and jurisdiction, Coscopin should not be given to a child without explicit advice from a paediatrician or qualified healthcare provider.

Possible side effects of Coscopin may include mild drowsiness, dizziness, headache, nausea, vomiting, abdominal discomfort, or diarrhoea. Some individuals may experience dry mouth or a change in taste. Hypersensitivity reactions such as skin rash, itching, or swelling can occur but are less common. Very rarely, more serious reactions such as difficulty breathing or severe allergic responses may develop. If any severe or persistent side effects occur, the medicine should be stopped and medical attention sought promptly.

Coscopin should be used cautiously with other cough or cold medicines, especially those that also contain antitussives, antihistamines, decongestants, or sedatives, because combined use can increase the risk of drowsiness, dizziness, or other adverse effects. Some over‑the‑counter products may contain similar or overlapping ingredients. It is important to read labels carefully and consult a healthcare professional or pharmacist before combining Coscopin with any other cough, cold, or allergy medication.

Data on the safety of noscapine‑containing combinations such as Coscopin in pregnancy are limited. As a precaution, use during pregnancy is generally not recommended unless the potential benefit to the mother clearly outweighs any possible risk to the fetus, and only under direct medical supervision. Pregnant women should consult their obstetrician or healthcare provider before using Coscopin or any other cough preparation.

Information on the excretion of noscapine and other components of Coscopin into human breast milk is limited. Because of the potential for central nervous system effects in the breastfed infant and the lack of robust safety data, use during breastfeeding should be approached with caution. A healthcare professional should be consulted to weigh the benefits of treatment for the mother against any potential risk to the infant, and alternative non‑sedating options may be considered.

Noscapine may cause drowsiness, dizziness, or reduced alertness in some individuals. Until you know how Coscopin affects you, driving, operating machinery, or performing tasks that require full mental concentration should be avoided. If you experience any sedation, blurred vision, or impaired coordination after taking Coscopin, you should not drive or use heavy machinery and should discuss these symptoms with your healthcare provider.

If your cough persists for more than a few days, worsens, or is accompanied by high fever, chest pain, difficulty breathing, wheezing, blood in sputum, or unexplained weight loss, you should stop self‑medication and seek medical evaluation promptly. Persistent or severe cough may indicate a more serious underlying condition that requires specific diagnosis and targeted treatment. Coscopin is intended only for short‑term symptomatic relief and should not be used as a long‑term solution without medical supervision.

Coscopin may be unsuitable for individuals with known hypersensitivity to noscapine, ammonium chloride, sodium or trisodium citrate, or any excipients in the formulation. It should be used cautiously or avoided in patients with severe liver or kidney impairment, significant respiratory depression, chronic productive cough with large amounts of sputum, or a history of severe allergic reactions to similar products. Patients with chronic respiratory diseases, cardiovascular disease, or those taking multiple medications should consult a healthcare professional before using Coscopin.